2 December 2021 – DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures, Solva...
• Milan based Epsilen Bio is acquired by Chroma Medicine, which launches today with $125M in financing • Epsilen Bio, now a wholly owned subsidiary of Chroma Medicine, will continue to conduct groundbreaking epigenetic editing R&D in Milan in collaboration...
The fund will invest in companies leveraging biotechnology to develop sustainable solutions Sofinnova Industrial Biotech II is part of the VC firm’s pioneering strategy initiated over a decade ago PARIS, France – November 17, 2021 - Sofinnova Partners, a leadi...
Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leading Life Sciences Software Company That Transforms the Way Scientists Automate Experimentation and Share Insights November 16, 2021 04:30 AM Eastern Standard Time
November 09, 2021 03:00 AM Eastern Standard Time PARIS--(BUSINESS WIRE)--Home Biosciences, Europe’s first venture builder fully dedicated to biotech, announced today a $15 million Seed financing led by Redmile Group and Sofinnova Partners.
